Trials / Unknown
UnknownNCT04509986
GlobalSurg-CovidSurg Week
GlobalSurg-CovidSurg Week: Determining the Optimal Timing for Surgery Following SARS-CoV-2 Infection
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- University of Birmingham · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Observational study to determine the optimal timing for surgery following SARS-CoV-2 infection and assess key global surgery indicators.
Detailed description
* Prospective, observational international cohort study. * Any hospital worldwide can participate (including hospitals that have not admitted SARS-CoV-2 infected patients). * All patients undergoing a surgical procedure in an operating theatre will be included. All consecutive eligible patients should be included. * 7-day data collection period, with follow-up at 30 days after surgery for each patient. However, no changes should be made to normal patient care/ follow-up pathways * Primary outcome is 30-day mortality. * All collaborators will be included as PubMed-citable co-authors on resulting publications.
Conditions
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2020-10-31
- Completion
- 2020-12-01
- First posted
- 2020-08-12
- Last updated
- 2020-08-12
Source: ClinicalTrials.gov record NCT04509986. Inclusion in this directory is not an endorsement.